Our team of experts at Valley Eye Associates understands that glaucoma can be an overwhelming and daunting diagnosis, and because it is, we constantly use and study the most advanced vision technologies. A recently created medical device has helped take the anxiety out of glaucoma treatment: the Hydrus Microstent.
The Hydrus Microstent is a flexible device that stimulates drainage in the eye. Only the size of an eyelash, the stent effectively reduces intraocular pressure and helps manage glaucoma.
This device is approved for use during cataract surgery, but the procedure is minimally invasive, so patients can expect fewer complications and a quicker healing time than traditional glaucoma procedures. Patients won’t be able to feel or see the stent. If you are an adult with mild to moderate primary open angle glaucoma and you will be undergoing cataract surgery, you may be a candidate for this device.
The Hydrus Microstent is installed in Schlemm’s canal — a circular vessel that maintains homeostasis in the eye — widening the eye’s natural outflow channel which allows fluid to flow more freely, decreasing intraocular pressure. This stent spans 90 degrees of Schlemm’s canal, and because it does, fluid more easily reaches the eye’s drainage system, which distributes it to the circulatory system.
The Hydrus Microstent’s success is evident:1
- After two years, 78% of Hydrus Microstent patients didn’t need drops.
- Hydrus Microstent patients experienced a 61% reduction in invasive secondary surgeries compared to cataract surgery alone.
- Compared to the control of a micro invasive glaucoma trial, the Hydrus Microstent showed the greatest intraocular pressure reduction.
- Most notably, the Hydrus Microstent is clinically proven to eliminate the necessity of glaucoma medication.
We value you and your vision. That’s why we’re furthering our practice with some of the best eye care technologies. Don’t wait to treat your glaucoma. Call (800) 344-4443 to schedule an appointment.